Comprehensive Molecular Characterization Identifies Distinct Genomic and Immune Hallmarks of Renal Medullary Carcinoma
Pavlos Msaouel(The University of Texas MD Anderson Cancer Center), Nizar M. Tannir(The University of Texas MD Anderson Cancer Center), Federica Carbone(The University of Texas MD Anderson Cancer Center), Wei Lü(The University of Texas MD Anderson Cancer Center), Katharina Schlacher(The University of Texas MD Anderson Cancer Center), Dolores López‐Terrada(Baylor College of Medicine), Christopher G. Wood(Massachusetts Eye and Ear Infirmary), Jean‐Philippe Bertocchio(The University of Texas MD Anderson Cancer Center), Menuka Karki(Baylor College of Medicine), Patrick G. Pilié(The University of Texas MD Anderson Cancer Center), Ximing Tang(The University of Texas MD Anderson Cancer Center), Luigi Perelli(The University of Texas MD Anderson Cancer Center), Virginia Giuliani(The University of Texas MD Anderson Cancer Center), Asha S. Multani(The University of Texas MD Anderson Cancer Center), Irwin Davidson(Centre National de la Recherche Scientifique), Timothy C. Thompson(The University of Texas MD Anderson Cancer Center), Giannicola Genovese(The University of Texas MD Anderson Cancer Center), Chad J. Creighton(Baylor College of Medicine), Alessandro Carugo(The University of Texas MD Anderson Cancer Center), Cristian Coarfa(Baylor College of Medicine), Priya Rao(The University of Texas MD Anderson Cancer Center), Gabriel G. Malouf(Centre National de la Recherche Scientifique), Timothy P. Heffernan(The University of Texas MD Anderson Cancer Center), Jorge Blando(AstraZeneca (Netherlands)), Riyad N. H. Seervai(Baylor College of Medicine), Jianjun Gao(Chinese General Hospital College of Nursing and Liberal Arts), Padmanee Sharma(The University of Texas MD Anderson Cancer Center), Xiaoping Su(Guangxi Medical University), José A. Karam(The University of Texas MD Anderson Cancer Center), Durga Nand Tripathi(Baylor College of Medicine), Rong He(Mayo Clinic), Cheryl L. Walker(Baylor College of Medicine), Bujamin Vokshi(Johns Hopkins University), Sanjana Srinivasan(The University of Texas MD Anderson Cancer Center), Daniel D. Shapiro(University of Wisconsin–Madison), Hui Yao(Jinan University), Emily H. Cheng(University of Wisconsin–Madison), Selvi Kunnimalaiyaan(Medical College of Wisconsin), Ignacio I. Wistuba(The University of Texas MD Anderson Cancer Center), Melinda Soeung(The University of Texas MD Anderson Cancer Center)
Cited by 142
Related Papers
UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses
|Neoplasia|2017|6.5k
UALCAN: An update to the integrated cancer data analysis platform
|Neoplasia|2022|2.5k
Validation of the ITS2 Region as a Novel DNA Barcode for Identifying Medicinal Plant Species
|PLoS ONE|2010|1.7k
Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features
|Proceedings of the National Academy of Sciences|2009|1.4k